# Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults

> **NCT03039491** · EARLY_PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 160 (actual)

## Conditions studied

- HIV Lipodystrophy
- Aging

## Interventions

- **BIOLOGICAL:** Pneumococcal polysaccharide vaccine 23 valent
- **BIOLOGICAL:** 13 valent conjugated pneumococcal vaccine

## Key facts

- **NCT ID:** NCT03039491
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03039491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03039491, "Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03039491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*